Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations

    January 2021 in “ Journal of Clinical Immunology
    Giuliana Giardino, Svetlana Sharapova, Peter Čižnár, Fatima Dhalla, Luca Maragliano, Akella Radha Rama Devi, Candan İslamoğlu, Aydan İkincioğulları, Şule Haskoloğlu, Figen Doğu, Rima Hanna‐Wakim, Ghassan Dbaibo, Janet Chou, Emilia Cirillo, Carla Borzacchiello, Alexandra Y. Kreins, Austen Worth, Ioanna A. Rota, José Gonçalo Marques, Müge Sayitoğlu, Sinem Fırtına, Moaffaq Mahdi, Raif S. Geha, Bénédicte Neven, Ana E. Sousa, Fabio Benfenati, Georg A. Holländer, E. Graham Davies, Claudio Pignata
    TLDR FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.
    The study investigated the expanded phenotype associated with FOXN1 mutations in a cohort of 18 patients, including 11 homozygous, 2 compound heterozygous, and 5 heterozygous individuals, all with recurrent severe infections. It was found that while congenital athymia, alopecia, and nail dystrophy are hallmark features of the syndrome, they were not always present. Nearly 50% of the patients developed Omenn syndrome, and a SCID-like phenotype was observed in 4 heterozygous patients from the same family. The study suggested that the clinical severity is influenced by the residual activity of the gene product, and in the heterozygous family, a negative dominance mechanism or additional mutations might be involved.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results